CONTINUING MEDICAL EDUCATION (CME) QUESTIONS|
November 16, 2023
Fractionated vs single-dose gemtuzumab for AML
CME
Blood (2023) 142 (20): 1759.
Connected Content
A related article has been published:
Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial
Citation
Fractionated vs single-dose gemtuzumab for AML. Blood 2023; 142 (20): 1759. doi: https://doi.org/10.1182/blood.2023022657
Download citation file: